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ABSTRACT
Cardiovascular diseases (CVDs) have been recorded as the number one cause of death worldwide,
accounting for 32% of total deaths annually. More than two-thirds of all CVD cases are associated
with atherosclerosis, which is the accumulation of fats and other substances causing plaque
formation in the interior walls of major arteries. This leads to narrowing of the lumen and
hardening of the arteries, ultimately resulting in angina, heart attack and/or stroke. Studies have
shown that the pathogenesis of atherosclerosis and associated CVDs is strongly linked to elevated
secretion of liver-specific lipoproteins called very-low-density-lipoprotein (VLDL). VLDLs are
crucial lipoproteins responsible for transportation of triacylglycerides (TAGs), chemically inert
particles that are physiologically significant for their energy storing capacity, from the liver to
peripheral tissues. These VLDL particles are synthesized in the lumen of the endoplasmic
reticulum (ER) of hepatocytes, transported from the ER to the cis-Golgi in special transport
vesicles called VLDL-transport-vesicles (VTVs) and secreted into plasma through a highly
regulated secretory pathway. Previous studies from our laboratory have shown that VTV-mediated
ER-to-Golgi VLDL trafficking is the rate-limiting step in overall VLDL secretion from
hepatocytes into plasma. In this project, we investigated intracellular VLDL trafficking and VLDL
secretion in Ames dwarf (Prop1df, df/df) mice, a mutant mouse model homozygous for a recessive
mutation at Prop1 gene locus (Prop1df) having deficiency of growth hormone (GH), thyroid
stimulating hormone (TSH) and prolactin (PRL). This model is characteristic of prolonged
longevity (~50% longer) and improved insulin sensitivity in comparison to their wild-type (N)
counterparts. Ames dwarf (df/df) mice have recently been shown to have highly reduced plasma
TAG levels, associating them with reduced susceptibility to atherosclerosis and associated CVDs.
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The underlying mechanism responsible for reduced VLDL secretion in Ames dwarf mice is yet to
be characterized. We hypothesize that VTV-mediated trafficking of VLDL is reduced in Ames
dwarf mice because of reduced expression of proteins regulating VLDL and VTV formation. To
test our hypothesis, we first performed VTV-budding assay using cellular fractions isolated
separately from Ames dwarf (df/df) and wild-type (N) mice livers. Our results show a significant
(45%) reduction in VTV-budding process in Ames dwarf (df/df) mice compared to wild-type (N).
Next we performed 2-dimensional differential gel electrophoresis (2-DIGE) on VTV and whole
cell lysate (WCL) samples in order to examine the differences in protein expression and to have
highly specific protein separation. ExPASy database was used to analyze protein spots that allowed
us in identifying proteins specifically expressed in each of the mouse groups. Employing western
blotting, samples (ER, cytosol, VTV and WCL) from both sets of mice were tested for expression
levels of VLDL and VTV associated proteins (ApoB100, Sec22b, CideB, MTP, Apo-A1 and ApoAIV) with β-actin as the loading control. Significant differences in expression level of these
proteins were observed which strongly suggest that the formation of VTV from ER in male Ames
dwarf (df/df) mice is reduced compared to wild-type (N). Overall, we conclude that the differential
expression of proteins required for VLDL transport causes reduced VLDL secretion in male Ames
dwarf (df/df) mice.
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I dedicate this thesis to myself and everyone who has ever helped me come so far in life.
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CHAPTER ONE: INTRODUCTION
Atherosclerosis
In 2014, World Health Organization (W.H.O) statistics (source: W.H.O factsheet fs317) showed
that 32% of total deaths annually recorded were due to cardiovascular diseases (CVDs) making it
the number one cause of death worldwide. Of all the CVD cases, 68% have been recorded to be
associated with atherosclerosis. Prevalence of atherosclerosis in U.S.A alone has resulted in an
estimated economic cost of $350 billion and it is only going to increase gradually. The
pathogenesis of atherosclerosis and associated CVDs, as shown by studies [1, 2], has been strongly
linked to elevated secretion of liver-specific lipoprotein particles called very-low-densitylipoprotein (VLDL) particles.

Figure1: Deaths caused by Cardiovascular Diseases (CVDs) globally, 2014. [W.H.O factsheet
fs317]
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Very-Low-Density-Lipoprotein (VLDL)

(A) Biogenesis
Liver is one of the most important organs in the human body being capable of performing
numerous functions singlehandedly. One of the significant functions of liver involves its ability to
transport triglycerides (TAGs) throughout the body. These TAGs are concentrated form of fats
required for cell survival significant for storage and yielding high energy. TAGs are chemically
inert biomolecules. Therefore they cannot be secreted into blood directly. Liver also solves this
problem by packaging TAGs into lipoprotein particles called VLDL particles. This signifies the
role of VLDLs as crucial lipoproteins responsible for transportation of TAGs from liver to
peripheral tissues. VLDLs are synthesized in the luminal cavity of endoplasmic reticulum (ER) of
hepatocytes (liver cells) and secreted into plasma through a highly regulated secretory pathway.
The biogenesis process starts post translation when the core VLDL protein, Apolipoprotein B
(APOB), is being translocated into the luminal cavity of the endoplasmic reticulum (ER). APOB
is received inside the ER lumen by microsomal triglyceride transfer protein (MTP) and its
heterodimer PDI concomitantly. Once 28 kilo Dalton (kDa) long APOB has been received, it
undergoes protein folding along with initial lipidation by MTP. MTP has the ability to transfer
both neutral and polar lipids. This leads to the development of a nascent-VLDL particle and is
dependent on the availability of TAGs [3, 4]. It has been shown by recent studies [5] [6] that CideB
(cell death inducing DFFA45-like effector) protein also participates in formation of nascent-VLDL
particles by lapidating APOB molecule. Formation is following by transport of nascent VLDL
particles in special vesicles called VLDL-transport-vesicle (VTV) from the surface of ER to cisGolgi [7].
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(B) Vesicle Formation
Nascent VLDL particles are secreted from the ER in a coat protein complex II (COPII)-dependent
vesicles [7, 8]. The COPII-dependent VTV vesicle formation is initiated when Sar1b protein in its
GTP form is recruited by the ER membrane which consequently is followed by recruitment of
Sec23-24 and Sec13-31 [9, 10]. Studies have proven that Sar1b protein expression is critical to the
formation of VTVs and any mutation in the Sar1b gene suppresses the overall secretion of VLDL
significantly. Another crucial protein in this process is CideB which plays an essential role in VTV
formation [5]. It was shown that CideB interacts with APOB along with the COPII proteins
facilitating the formation of VTV around the nascent-VLDL particle [5].

(C) Trafficking
Once VTVs bud off from the ER membrane they recruit soluble N-ethylmaleimide-sensitive factor
attachment protein receptor (SNARE) protein [11-13]. The SNARE proteins which associate with
vesicles are termed vesicle-SNARE (v-SNARE) proteins and those which are present on the
surface of the target membrane are called target-SNARE (t-SNARE) proteins. Both v-SNARE and
t-SNARE form a complex to mediate the fusion of the membranes and delivery of the cargo form
the vesicle. Sec22b has been shown by studies [14], as the distinctive VTV v-SNARE protein,
crucial in the fusion of VTV with cis-Golgi. The corresponding t-SNARE proteins for Sec22b to
form a complex have also been identified by the same study as rBet1, Syntaxin5 and GOS28 [14].
This VTV-mediated trafficking of VLDL from ER to Golgi has been identified as the rate limiting
step in the overall secretion of VLDL into plasma from hepatocytes [15, 16].
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Figure 2: Schematic representation of the rate-limiting step, VTV-mediated ER to Golgi transport
of VLDL, in overall VLDL secretion from hepatocytes.

Ames Dwarf (df/df) Mice
Ames dwarf (df/df) mice first discovered in the 1950’s in a colony of laboratory mice at University
of Iowa in Ames. These are a mutant model homozygous for a recessive single point mutation at
Prop1 gene locus (Prop1df), directly upstream from homeotic factor Pit-1. Pit-1 is responsible for
the development of a specific region in the anterior pituitary gland which synthesizes growth
hormone (GH), prolactin (PRL) and thyroid stimulating hormone (TSH). Therefore these dwarf
mice are deficient in GH, PRL and TSH [17]. The deficiency of GH affects insulin, IGF-1 and GH
signaling pathways and this study is performed in search of better understanding between GH
deficiency and VLDL secretion in hepatocytes.
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Characteristics of Ames Dwarf (df/df)
Earlier it was understood by the scientific community that deficiency of growth hormone (GH)
was the reason behind the pathogenesis of cardiovascular diseases in mammals. As GH production
decreases overtime, the development of diseases due to inefficiency of immune system in humans
and mice was correlated to GH deficiency. However, research in the past few decades has given
us a much better and concrete understanding about the notion behind GH and its role in human
physiology. And this understanding has been contributed majorly by Ames dwarf (df/df) mice as
research is continuously helping us understand more about its prolonged longevity [~50% longer
than wild-type (N)] in relation of being GH deficient. These Ames (df/df) mice have been observed
to exhibit phenotypic characteristics such as delayed aging, prolonged longevity (~50% longer),
improved insulin sensitivity etc.

VLDL Secretion in Ames Dwarf (df/df)
It has been well documented that higher TAG levels in hepatocytes corresponds to higher VLDL
secretion in subjects which show higher risk association to atherosclerosis and associated CVDs.
Recently, it was shown that Ames dwarf (df/df) mice were found to have reduced plasma TAG
levels along with elevated liver TAG levels in comparison to their wild-type (N) siblings [18].
This observation seems to indicate a unique regulatory mechanism in Ames dwarf (df/df) mice
which helps them retain TAG inside hepatocytes. Another important thing to consider is that there
is no indication of liver steatosis in Ames dwarf (df/df) mice as a result of high TAG levels in the
liver. The presence of such a regulatory mechanism needs to be investigated as it could possibly
lead us to better understanding of the signaling mechanism behind reduction in VLDL secretion
in these dwarf mice.

5

CHAPTER TWO: METHODOLOGY
Materials
For cell culture experiments, McA-RH7777 cells, DMEM media and fetal bovine serum (FBS)
were purchased from American Type Culture Collection (ATCC); rat growth hormone (r-GH) was
purchased from Abcam Plc; [3H]-Oleic acid (45.5 Ci/mM) was purchased from PerkinElmer Life
Sciences; BSA-Oleic acid was purchased from Sigma Aldrich. For preparing whole cell lysate
(WCL), radio immunoprecipitation (RIPA) buffer was obtained from Thermo Fisher Scientific;
protease inhibitor cocktail tablets (catalogue number 04693116001) were purchased from Roche
Applied Sciences. For 2D-DIGE experiments, all the reagents and materials were purchased from
GE Healthcare. For gel electrophoresis experiments, immunoblotting reagents were obtained from
Bio-Rad (Hercules, CA); enhanced chemiluminescence (ECL) reagents were purchased from GE
Healthcare; other reagents used were of analytical grade and purchased from local companies.
Liver tissues from Ames dwarf (df/df, PROPdf) mice and their wild-type (N) controls were
acquired as a gift from Dr. Michal M. Masternak (Associate Professor, UCF). All procedures
involving mice were conducted according to the guidelines of University of Central Florida
Institutional Animal Care and Use Committee (IACUC) and strictly followed IACUC approved
protocol.

Antibodies
Rabbit polyclonal anti-ApoB (Apolipoprotein B) antibody was made commercially (Protein Tech
Group) via a synthetically produced peptide corresponding to amino acids 2055-2067 of rat ApoB.
Mouse polyclonal antibodies to microsomal triglyceride transfer protein (MTP), SEC22B,
Apolipoprotein AI (ApoAI) and β-Actin; rabbit polyclonal anti-ApolipoproteinAIV (ApoAIV)
6

antibody; goat polyclonal anti-CideB antibody were all purchased from Santa Cruz Biotechnology,
Inc.

Culturing of McA-RH7777 Cells
Briefly, McA-RH7777 cells (0.2 – 0.3 million per well) were plated in a 6-well plate in 10%
FBS/DMEM media overnight. Cells were then incubated with [3H]-labelled OA + BSA-OA +
0.5% FBS/DMEM media for 60 minutes; washed with PBS. This was followed by the incubation
of cells with rat-GH (100ng/ml) + DMEM media for 24 hours. Media (200 µl) was collected at
time points of 0 mins, 30 mins, 1, 2,4,24 hours.

Measurement of Radioactivity
Radioactivity pertaining to VLDL particles (comprising of [3H]-TAG) in media samples were
measured in terms of disintegrations per minute (d.p.m.) using Tri-Carb 2910TR liquid
scintillation analyzer (PerkinElmer Life Sciences) [5].

Preparation of Hepatic Endoplasmic Reticulum (ER)
Hepatic ER was prepared from the same protocol described previously [5, 7]. Briefly, mice
hepatocytes obtained via perfusion of mice liver were incubated in Buffer B (136 mM NaCl, 11.6
mM KH2PO4, 8 mM Na2HPO4, 7.5 mM KCl, 0.5 mM DTT; pH 7.2) along with BSA bound [3H]oleate (100 µCi) for 35 minutes at 37 ̊C. Cells were then washed with 2% BSA in PBS to remove
excess of [3H]-oleate. 0.25 M sucrose in 10 m M Hepes along with 50 mM EDTA and protease
inhibitor (Roche Diagnostic GmbH, Germany) was used to homogenize the cells in a Parr bomb
at 1100 psi for 40 minutes. This was followed by isolation of ER via a sucrose step gradient which
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was repeated to enhance the purity of ER [5, 7]. After procurement of ER, the protein concentration
was determined using Bradford method and the purity was tested by Western blotting method
using marker proteins as described earlier.

Preparation of Hepatic Cytosol
We prepared hepatic cytosol following previously described protocols [5, 7]. Briefly, cytosol
buffer [25 mM Hepes, 125 mM KCl, 2.5 mM MgCl2, 0.5 mM DTT and protease inhibitor cocktail
(pH 7.2)] was used to wash freshly isolated mice hepatocytes, which were homogenized using a
Parr bomb at 1100 psi for 40 mins. The sample was subjected to ultracentrifugation at 100,000 g
for 95 min (Beckman 70.1 Ti rotor) and the supernatant (cytosol) was collected. Dialysis of the
cytosol against cold cytosol buffer was performed at 4 ̊C overnight. Finally, a centricon filter
(Amicon) and ultra-filtration membrane (Millipore) with a 10 kDa cut-off was used to concentrate
the cytosol sample to a final concentration of ~20 mg/ml. The concentration was determined via
Bradford assay and the purity of hepatic cytosol was determined via western blots using marker
proteins for ER.

Preparation of Hepatic Whole Cell Lysate (WCL)
Mice hepatic whole cell lysate was prepared by following the exact same protocol mentioned
previously [5]. Briefly, primary mice hepatocytes were subjected to lysis using RIPA buffer along
with protease inhibitor cocktail and subjected to centrifugation at 13,000 g for 15 minutes. The
resultant supernatant was collected and its protein concentration was calculated via Bradford
method.
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In vitro VTV Budding
The in vitro VTV budding was performed exactly the same as previously established protocol in
our laboratory [7, 19, 20]. Briefly, 500 µg protein of hepatic ER containing [3H]-TAG was
incubated with 1000 µg protein of hepatic cytosol along with 1 mM GTP and an ATP-regenerating
system (1mM ATP, 5mM phosphocreatine and 5 units of creatine phosphokinase) for 30 minutes
at 37 ̊C. Post-incubation, continuous sucrose density gradient (0.1 - 1.15 M sucrose) was used to
resolve the mixture. Fractions of 0.5 ml volume were collected and the [ 3H]-TAG associated
radioactivity was determined using the protocol mentioned earlier.

Two-Dimensional Differential Gel Electrophoresis (2D-DIGE)
2D-DIGE experiment was performed following the same protocol described previously [19].
Briefly, we used a total of 100 µg protein for sample preparation. First, 50 µg protein each from
both group of mice were solubilized separately in equal volume of lysis solution [7M urea, 2M
thiourea, 4% CHAPS, 2mM tri-butyl phosphine (TBP), 0.5% carrier ampholyte (pH 3–10), 40mM
Tris] for 15 minutes. Proteins from wild-type (N) and Ames (df/df) were stained with Cy5 and
Cy3 dye respectively by mixing with 1 µl of diluted CyDye. This mix was incubated for 30 minutes
in the dark at 4 ̊C. 1 μl of 10mM lysine was then added to stop the reaction. Both samples were
then mixed together and 2D rehydration buffer was added to result in a final volume of ~200 µl.
This mixture was then incubated at 37 ̊C for 1 hour and finally loaded onto immobilized pI gradient
gel (IPG) strips (pH 3–10) by overnight incubation at room temperature.
The next step was isoelectric focusing (IEF) and was performed following the protocol provided
by GE Healthcare. A total of 50,500 volt-hours are applied to each IPG strip as the complete IEF
process lasts for 21 hours. After IEF, the IPG strip was subjected to 10 minute washes, first with
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equilibration buffer I [0.5M Tris–HCl pH 6.8, 6M urea, 30% glycerol (v/v), 2% SDS, 25mM DTT]
and then with equilibration buffer II [0.5M Tris–HCl pH 6.8, 6Murea, 30% glycerol (v/v), 2%
SDS, 12mMiodoacetamide].
IEF was followed by separation of proteins via a gradient gel (8–18% SDS-polyacrylamide gel)
on top of which the IPG strip was loaded. The SDS-gel was run at a constant current of 20 mAmps
for 6-7 hours at 15 °C until the dye front was running out of the gel.
The final step was gel image scanning which was performed using Typhoon TRIO (GE
Healthcare) immediately after gel electrophoresis ended. Consequently, the protein spots on the
scanned images were further analyzed using the online portal of ExPASy’s SWISS-2DPAGE
(Swiss Institute of Bioinformatics).

Immunoblot Analysis and SDS-PAGE
Bradford assay was used to determine the concentration of protein in ER, Cytosol, VTV and WCL
samples [7]. Protein samples (40 µg) from Wild-type (N) and Ames (df/df) were separated via
SDS-PAGE (4%-20%) and trans blotted onto a nitrocellulose membrane (Bio-Rad) overnight at
4 ̊C. 10% (w//v) non-fat dried skimmed milk powder in PBS-T (PBS with 0.05% Tween 20) was
used for blocking the membrane, followed by incubation with specific primary antibodies and
relevant HRP-conjugated secondary antibodies [21]. ECL Western blot detection reagent (GE,
Healthcare) and autoradiography film (MIDSCI, MO) were used for detection of proteins.
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CHAPTER THREE: FINDINGS
In vitro Effect of Rat Growth Hormone (r-GH) on VLDL Secretion
To test the association of reduced plasma TAG levels to smaller liver size in Ames (df/df) mice,
we investigated the effect of growth hormone on VLDL secretion in vitro. McA-RH7777 cells were
subjected to 1 hour incubation with [3H]-labelled OA + BSA-OA + 0.5% FBS/DMEM, followed
by incubation with rat growth hormone (100ng/ml) for 24 hours. Media was collected at time
points of 0 mins, 30 mins, 1, 2,4,24 hours and subjected to d.p.m count. Results obtained suggest
that under in vitro conditions GH does affect VLDL secretion [Fig. 1]. This result is in accordance
with previous studies [22, 23] on effects of GH on production and secretion of ApoB, structural
protein of VLDL particles. Therefore, we have ruled out the association of reduced plasma TAG
levels in Ames (df/df) mice to its smaller liver size.

Reduced VTV Budding in Ames Dwarf (df/df) Mice
The rate limiting step in the overall secretion of VLDL from hepatocytes is its transport from its
site of synthesis, ER, to cis-Golgi in VTV [7, 15]. In order to test any alterations in this rate limiting
step, we compared the degree of VTV biogenesis in both groups of mice via a VTV budding assay.
For this assay, equal quantities of protein samples were used from both groups of mice. To initiate
budding of VTV, ER sample was incubated in cytosol along with an ATP regenerating system at
37 ̊C for 1 hour. After this incubation, a continuous sucrose gradient was used to resolve the
reaction mixture through ultracentrifugation. The complete sucrose gradient had been fractionated
by aspiration into fractions of 0.5 ml volume each, and [3H]-TAG d.p.m counts associated with
every fraction was determined. Lighter-density fractions with higher [3H]-TAG d.p.m indicated
higher VTVs.
11

Results showed that the average of D.P.M counts of fractions containing VTVs from Ames (df/df)
mice samples were found to be 45% less in comparison to the same fractions from wild-type (N)
mice [Fig. 2]. This difference is highly significant and provides crucial evidence illustrating the
fact that there exists a regulatory mechanism causing reduced VLDL secretion in Ames (df/df)
mice. It also helps in establishing a link between our hypothesis and the reduced TAG levels
observed in Ames (df/df) mice. This result provides us the platform to further analyze and identify
the cellular mechanisms/proteins/other factors behind this regulation in relation to reduced VLDL
secretion.

Analyzing Protein abundance
In order to have higher specificity while analyzing protein expression in both wild-type (N) and
Ames (df/df) mice hepatocytes, we performed 2D-DIGE where separation of proteins takes place
through two parameters [Isoelectric point (pI) and molecular weight (Mw)]. 2D-DIGE was first
performed on hepatic WCL samples and then on VTV samples from both groups of mice.
Interestingly, the results showed us protein spots specific to each sample [Fig. 3, 4]. Consequently
the pI and Mw axial coordinates for these spots were noted carefully and these coordinates became
the feeder information for the online protein database ExPASy SWISS 2D-PAGE. Table 1 shows
the list of proteins identified specific to samples of each mouse group. This list of proteins were
further investigated to find any cellular mechanism in which they played a role with a possible link
towards VLDL and VTV biogenesis. We found out Cathepsin B (CATB), protein involved in
secretory pathway of pancreatic and chromaffin cells [24, 25], to be expressed only in wild-type
(N) samples and either highly suppressed or not expressed in Ames dwarf (df/df). This is
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interesting based on the fact that CATB has not yet been investigated pertaining to VLDL secretion
from hepatocytes and this result gives us evidence to test it.

Comparing Basal Expression Level of VLDL-Synthesis and VTV-Biogenesis associated
Proteins
Having found differences in protein expression through our 2D-DIGE results, it was imperative
for us to test the basal expression level of VLDL and VTV biogenesis specific proteins in both
groups of mice. Samples (40 µg each) used to compare the basal expression levels of proteins
include ER, Cytosol, VTV and WCL. The protein bands visible on the autoradiography film were
quantified using ImageJ software. All the results were quantified using β–Actin as the loading
control.
We started with testing Apolipoprotein B (ApoB), principal lipoprotein mandatory for synthesis
and secretion of VLDL [26]. ApoB has earlier been shown to play a central role in hepatic
lipoprotein metabolism [27]. Elevated secretion of ApoB from hepatocytes or decreased removal
from plasma causes increased plasma concentration of ApoB, a highly lethal condition causing
increased risk for pathogenesis of atherosclerosis [28-30]. The comparative results obtained
showed ~50% elevated expression in Ames (df/df) ER; ~50% reduced expression in Ames (df/df)
Cytosol; ~80% reduced expression in Ames (df/df) VTV and no differences in WCL samples [Fig.
7 (a)]. From these results we comprehend that VLDL at its site of synthesis, i.e. ER, in Ames
(df/df) mice is getting accumulated.
Next, we tested for microsomal triglyceride transfer protein (MTP), a molecular chaperone
residing specifically in luminal cavities of ER and Golgi. MTP along with its heterodimer, PDI,
plays a crucial role in translocation and assembly of ApoB [31]. It has also been shown to assist in
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the early-stage lipidation of ApoB [32]. Defects in MTP gene result in an autosomal recessive
disorder in hepatocytes called Abetalipoproteinemia [33], causing deficiencies in ApoB and
ultimately interferes with the normal absorption of fat and fat-soluble vitamins from food. Protein
expression comparative results show us no difference at ER level in both groups of mice whereas
we found ~35% lower expression in Ames (df/df) WCL [Fig. 5 (b)]. MTP expression at the ER
level in both groups of mice is unaltered meaning steps involving translocation and assembly of
ApoB are similar. However on an overall cellular level, the reason behind reduced expression in
Ames (df/df) mice still needs to be investigated.
MTP was followed by Cell-death Inducing DFFA-like Effector B (CIDE-B), another crucial
protein which not only mediates ApoB lipidation [6] but also triggers formation of VLDL-transport
vesicle (VTV) [5]. Our lab has already shown that knockdown of CideB results in significant
reduction in VTV biogenesis [5]. Results for CideB expression reveal ~35% reduced expression
in Ames (df/df) ER; ~50% reduced expression in Ames (df/df) Cytosol, ~60% reduced expression
in Ames (df/df) VTV and ~40% reduced expression in Ames (df/df) WCL sample [Fig. 7 (c)].
Reduced CideB expression strongly supports our hypothesis of an existing regulatory mechanism
for reduced VLDL secretion via reduction in expression of crucial proteins in Ames (df/df) group.
After CideB we tested for SEC22B, distinctive vesicle SNARE protein of VTVs mandatory for
fusion of VTV with cis-Golgi membrane [14]. The association of SEC22B to the surface of VTV
is crucial in both VTV-Golgi fusion and also in the delivery of VLDL particles to Golgi lumen
[14]. Our western blot ImageJ results show ~25% reduced expression in Ames (df/df) ER; ~70%
elevated expression in Ames (df/df) Cytosol; ~75% elevated expression in Ames (df/df) VTV and
~60% reduction in Ames (df/df) WCL sample [Fig. 7 (d)]. We comprehend that the highly reduced
and elevated expression of SEC22B in Ames (df/df) ER and Cytosol samples respectively possibly
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correlates to reduction in VTV budding in dwarf mice. However, further evidence is needed in
order to explain the actual mechanism.
As mature VLDL particles acquire ApoAI after VTV-mediated ER to Golgi transport, we next
tested for ApoAI protein expression. Apart from association with VLDL, ApoAI is also the
structural core protein for high-density-lipoprotein (HDL) particles which help in reverse
cholesterol transport, a crucial step in maintaining plasma TAG levels [34]. Results for ApoAI
show ~55% increased expression in Ames (df/df) ER; ~30% increased expression in Ames (df/df)
Cytosol; ~30% increased expression in Ames (df/df) WCL sample [Fig. 7 (e)]. ApoAI was not
observed in VTV sample as expected. These results strongly suggest us that Ames (df/df) mice are
efficient in the synthesis of ApoAI. However the correlation of ApoAI levels to overall VLDL
secretion needs further analysis at the Golgi and post-Golgi level.
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Figure 3: The in vitro effect of rat-GH on McA-RH7777 cells, 24 hour experiment. GH was
introduced at the start of the 24 hours and no supplemental supply of GH was given. 3H-TAG
were used to track the degree of VLDL secretion.’’ indicates significant difference in 3H-TAG
count pertaining to VLDL secretion. (p<0.05).
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Figure 4: VTV budding assay result; significant (45%) reduction in Ames dwarf (df/df) in
comparison to wild-type (N). (p<0.01)
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2D-DIGE whole cell lysate (WCL) Scans

A

B

C
Figure 5: 2D-DIGE WCL results. Scan of Cy5 stained wild-type (N) WCL sample (A); Scan of
Cy3 stained Ames dwarf (df/df) WCL sample (B); Overlap scan (C).
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2D-DIGE whole cell lysate (WCL) ExPASy results
Table 1: 2D-DIGE whole cell lysate (WCL) ExPASy results. Molecular weight (Mw) range and
isoelectric point (pI) range were used to obtain the results from ExPASy.
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2D-DIGE VTV Scans

A

B

C
Figure 6: 2D-DIGE VTV results. Scan of Cy5 stained wild-type (N) VTV sample (A); Scan of
Cy3 stained Ames dwarf (df/df) VTV sample (B); Overlap scan (C).
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2D-DIGE VTV ExPASy results
Table 2: 2D-DIGE VTV ExPASy results. Molecular weight (Mw) range and isoelectric point (pI)
range were used to obtain the results from ExPASy.
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Western blot results

Figure 7: Overview of Western Blot results
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a. Apolipoprotein B (APOB)

*

*

*

Figure 7 (a): Immunoblot results of ApoB samples from wild-type (N) and Ames dwarf (df/df)
samples
(A) ER samples; (B) Cytosol samples; (C) VTV samples; (D) WCL samples [p<0.05]
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b. Microsomal TAG Transfer Protein (MTP)

*

Figure 7 (b): Immunoblot results of MTP samples from wild-type (N) and Ames dwarf (df/df)
samples
(A) ER samples; (B) WCL samples. [p<0.05]
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c. Cell-death Inducing DFFA-like Effector B (CideB)

Figure 7 (c): Immunoblot results of CideB samples from wild-type (N) and Ames dwarf (df/df)
samples
(A) ER samples; (B) Cytosol; (C) VTV; (D) WCL samples [p<0.05]
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d. Sec22b

Figure 7 (d): Immunoblot results of Sec22b samples from wild-type (N) and Ames dwarf (df/df)
samples
(A) ER samples; (B) Cytosol samples; (C) VTV samples; (D) WCL samples [p<0.05]
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e. Apolipoprotein AI (APOAI)

Figure 7 (e): Immunoblot results of ApoAI samples from wild-type (N) and Ames dwarf (df/df)
samples
(A) ER samples; (B) Cytosol samples; (C) WCL samples [p<0.05]
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f. Apolipoprotein AIV (APOAIV)

Figure 7 (f): Immunoblot results of APOAIV samples from wild-type (N) and Ames dwarf (df/df)
samples
(A) ER samples; (B) Cytosol samples; (C) VTV samples; (D) WCL samples [p<0.05]
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CHAPTER FOUR: CONCLUSIONS
Maintenance of energy homeostasis in humans is crucial as any alterations could chronically lead
to complications and disorders. One of the most efficient mechanisms through which our body
transports and utilizes energy in our body is through fats, in absence of which our body would
heavily rely on carbohydrates and proteins ultimately leading to complications in overall
physiology and metabolism. Fats being physicochemically inert in nature cannot be transported
throughout the body through blood (polar in nature). This problem is solved in two steps: First,
fats are transported throughout our body in its most concentrated form of triacylglycerides (TAGs);
second, these TAGs are packaged into lipoprotein particles which can be directly secreted into
blood plasma. The two main organs of our body responsible for synthesis and secretion of
lipoprotein particles are small intestine and liver. In basal post absorptive state, majority of
lipoprotein synthesis in our body is carried out by liver [7] [26].
We have seen that GH does affect VLDL secretion from hepatocytes in rodents. However, we have
yet to establish complete understanding of the signaling mechanisms behind this. In this study, we
have investigated the rate-limiting step, VTV-mediated transport of VLDL from ER to Golgi, in
overall VLDL secretion from hepatocytes of long-lived Ames dwarf (df/df) mice. We found out
that the initiation of this rate limiting step, budding of VTV from the surface of ER, is significantly
(45%) reduced in Ames dwarf providing us evidence that a regulatory mechanism does exist in
Ames dwarf (df/df), in comparison to wild-type (N) mice, pertaining to overall VLDL secretion.
Consequently we wanted to test the abundance of hepatocyte proteome in both the mice groups
and in order to attain this we performed 2D-DIGE. Results from 2D-DIGE showed us proteins
which were highly suppressed or absent in Ames dwarf (df/df) mice. Interestingly we observed
Cathepsin B (CATB), protein shown by studies to be involved in intracellular trafficking in the
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secretory pathway of pancreatic cells and chromaffin cells [24, 25], only in wild-type (N) samples.
Although CATB has not been investigated yet to see if it plays any crucial role in VLDL secretion
from hepatocytes, the result gives us substantial reason to test it.
From our 2D-DIGE results, we also noticed that there were proteins pertaining to VLDL synthesis
and VTV formation whose expressions looked to be suppressed. And in order to test our
observations, we next resorted to Western Blot analysis to test the basal expression level of
established proteins known to regulate VLDL synthesis and VTV formation. Western blot results
were quantified using ImageJ software and we found out significant difference in expression of
each protein. Results showed us that APOB at the ER level in Ames dwarf (df/df) is either getting
accumulated or not being processed into nascent-VLDL particles as efficiently as compared to
wild-type (N) mice. Results from MTP show no difference meaning the translocation of APOB
into the ER lumen is the same in both groups of mice. It has been shown that knockdown or
knockout of CideB protein expression leads to suppression of VTV formation and overall VLDL
secretion from hepatocytes [5]. Significantly reduced CideB protein expression in Ames dwarf
(df/df) mice gives proof and shows us how VLDL synthesis and VTV budding are affected at the
ER level causing increased reduction in overall VLDL secretion.
In conclusion, we now know that there are differences in the hepatocyte proteome of Ames dwarf
(df/df) mice compared to wild-type (N) mice. We have also observed reduced (45%) VTV budding
at the ER level supported by reduced expression of CideB protein in Ames dwarf (df/df) mice.
Moving forward, the next step would be to characterize the role played by CATB in the overall
secretion of VLDL from hepatocytes.
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